Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up

Global biotech giant Roche has announced that the U.S. Food and Drug Administration (FDA) has awarded its candidate Alzheimer's Disease drug gantenerumab Breakthrough Therapy Designation, bringing it closer to finally getting a full FDA approval.